All In MedTech

Device Trial Radar · NCT02439502

EndoChoice's Fuse® Endoscopic System Performance In Routine Practice

Single Center, Prospective, Open Label Post Marketing Study of EndoChoice's Fuse® Endoscopic System Performance In Routine Practice

Last checked: Nov 19, 2026Latest source record: Jan 13, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

29

Actual

Start

Apr 2015

Primary completion

Dec 2016

Study completion Dec 2016

Sponsor

Lead sponsor
EndoChoice Innovation Center, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 8, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The intent of this study is to evaluate the performance and usability of Fuse in routine practice. The participants are indicated for upper (gastroscopy) and lower (colonoscopy) gastrointestinal endoscopy procedures. The study is open label, prospective and Post Marketing study.

Conditions

  • Miscellaneous Gastroenterology and Urology Devices Associated With Adverse Incidents, Not Elsewhere Classified

Interventions

  • Fuse® systemDevice

    Fuse® system will be used to perform gastro and endoscopic diagnostic procedures for upper and lower GI tract.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of findings (abnormal GI findings, such as polyps and tec.) per diagnostic procedure, using Fuse® systemTime frame: 1 outpatient hospitalization day for subject

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.